NEW YORK (GenomeWeb News) – Oxford Gene Technology said today that it has been working with Emory Genetics Laboratory to develop a menu of comparative genomic hybridization arrays focused on a variety of genetic disorders.

Together, the Oxford, UK-based company and EGL have designed more than 20 such chips, which enable the detection of copy number variants in genes associated with cardiovascular, inherited eye, intellectual disability, and neuromuscular disorders, as well as a range of inherited cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.